Expanding SYNP161 Technology to New Therapeutic Applications

The inventive concept disclosed herein leverages the core technology of SYNP161, a promoter for the expression of genes, to unlock new therapeutic possibilities in diverse fields, including dermatology, musculoskeletal health, respiratory medicine, oncology, and neuroscience.

The original SYNP161 patent focused on gene expression in rod photoreceptor cells. However, the limitations of this technology lie in its restricted applicability to a specific cell type. The inventive concept addresses this limitation by exploring the potential of SYNP161 in entirely new industries and problem spaces, thereby expanding its therapeutic reach and value.

The inventive concept involves applying the SYNP161 promoter technology to novel therapeutic applications, including treating skin conditions, enhancing muscle growth, combating respiratory diseases, detecting cancer, and improving cognitive function. This is achieved by combining the SYNP161 promoter with nucleic acid sequences encoding for specific genes, tailored to each target cell type or disease. The resulting expression cassettes, vectors, and compositions enable targeted gene expression, leading to innovative therapeutic solutions.

The inventive concept's novelty lies in its application of SYNP161 technology to entirely new fields and use cases, thereby expanding its therapeutic scope. The inventive step resides in the recognition of SYNP161's potential beyond its original application and the development of novel combinations and formulations that unlock its value in diverse therapeutic areas.

Alternative embodiments of the inventive concept could involve the use of different promoter sequences, gene combinations, or vector systems to achieve targeted gene expression. Variations could also include the application of SYNP161 technology to additional therapeutic areas, such as cardiology or immunology, or the development of novel delivery methods for the expression cassettes and vectors.

The inventive concept has significant commercial potential in various industries, including pharmaceuticals, biotechnology, and medical devices. The target markets include dermatology, musculoskeletal health, respiratory medicine, oncology, and neuroscience, with potential applications in both human and veterinary medicine.